Neurodegenerative diseases-Caps: a capsule network based early screening system for the classification of neurodegenerative diseases

被引:0
作者
Kirti Raj Bhatele
Anand Jha
Kavish Kapoor
Devanshu Tiwari
机构
[1] RJIT,
[2] BSF Academy,undefined
[3] Kavlabs,undefined
[4] RGPV,undefined
来源
Cognitive Neurodynamics | 2022年 / 16卷
关键词
Neurodegenerative diseases; Parkinson; Alzheimer; Capsule network; ResNet50; VGG 16; VGG 19; InceptionV3 etc.;
D O I
暂无
中图分类号
学科分类号
摘要
The two most generally diagnosed Neurodegenerative diseases are the Alzheimer and Parkinson diseases. So this paper presents a fully automated early screening system based on the Capsule network for the classification of these two Neurodegenerative diseases. In this study, we hypothesized that the Neurodegenerative diseases-Caps system based on the Capsule network architecture accurately performs the multiclass i.e. three class classification into either the Alzheimer class or Parkinson class or Healthy control and delivers better results in comparison other deep transfer learning models. The real motivation behind choosing the capsule network architecture is its more resilient nature towards the affine transformations as well as rotational & translational invariance, which commonly persists in the medical image datasets. Apart from this, the capsule networks overcomes the pooling layers related deficiencies from which conventional CNNs are mostly affected and unable to delivers accurate results especially in the tasks related to image classification. The various Computer aided systems based on machine learning for the classification of brain tumors and other types of cancers are already available. Whereas for the classification of Neurodegenerative diseases, the amount of research done is very limited and the number of persons suffering from this type of diseases are increasing especially in developing countries like India, China etc. So there is a need to develop an early screening system for the correct multiclass classification into Alzheimer’s, Parkinson’s and Normal or Healthy control cases. The Alzheimer disease and Parkinson progression (ADPP) dataset is used in this research study for the training of the proposed Neurodegenerative diseases-Caps system. This ADPP dataset is developed with the aid of both the Parkinson's Progression Markers Initiative (PPMI) and Alzheimer’s disease Neuroimaging Initiative (ADNI) databases. There is no such early screening system exist yet, which can perform the accurate classification of these two Neurodegenerative diseases. For the sake of genuine comparison, other popular deep transfer learning models like VGG19, VGG16, ResNet50 and InceptionV3 are implemented and also trained over the same ADPP dataset. The proposed Neurodegenerative diseases-Caps system deliver accuracies of 97.81, 98, 96.81% for the Alzheimer, Parkinson and Healthy control or Normal cases with 70/30 (training/validation split) and performs way better as compare to the other popular Deep transfer learning models.
引用
收藏
页码:1361 / 1377
页数:16
相关论文
共 50 条
  • [41] An efficient ranking-based ensembled multiclassifier for neurodegenerative diseases classification using deep learning
    Goyal, Palak
    Rani, Rinkle
    Singh, Karamjeet
    JOURNAL OF NEURAL TRANSMISSION, 2025, 132 (01) : 67 - 93
  • [42] Application of Network Pharmacology in the Treatment of Neurodegenerative Diseases with Traditional Chinese Medicine
    Chen, Qiang
    Chen, Guanghui
    Wang, Qianyan
    PLANTA MEDICA, 2025, : 226 - 237
  • [43] Plasma-Enabled Carbon Nanostructures for Early Diagnosis of Neurodegenerative Diseases
    Pineda, Shafique
    Han, Zhao Jun
    Ostrikov, Kostya
    MATERIALS, 2014, 7 (07) : 4896 - 4929
  • [44] Clinical importance of testing olfactory functions for early detection of neurodegenerative diseases
    Martoncíková, M
    Orendácová, J
    Raceková, E
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2003, 66 (01) : 3 - 7
  • [45] Advancing the Frontier: Neuroimaging Techniques in the Early Detection and Management of Neurodegenerative Diseases
    Akram, Ahmed S.
    Grezenko, Han
    Singh, Prem
    Ahmed, Muhammad
    Hassan, Baran Dilshad
    Anand, Vibhavari Hagenahalli
    Elashry, Abdelrahman A.
    Nazir, Faran
    Khan, Rehman
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [46] Olfactory Dysfunction as a Clinical Marker of Early Glymphatic Failure in Neurodegenerative Diseases
    Sanchez-Benavides, Gonzalo
    Iranzo, Alex
    Grau-Rivera, Oriol
    Giraldo, Darly Milena
    Buongiorno, Mariateresa
    DIAGNOSTICS, 2025, 15 (06)
  • [47] A Deep Learning-Based Approach to Detect Neurodegenerative Diseases
    Erdas, Cagatay Berke
    Sumer, Emre
    2020 MEDICAL TECHNOLOGIES CONGRESS (TIPTEKNO), 2020,
  • [48] Polymer-Based Electrochemical Sensors for the Diagnosis of Neurodegenerative Diseases
    Qitong Zhang
    Guangran Zhao
    Shilin Wang
    Yuxuan Song
    Yuanzheng Sun
    Cellular and Molecular Neurobiology, 45 (1)
  • [49] High-Throughput Screening Platforms in the Discovery of Novel Drugs for Neurodegenerative Diseases
    Aldewachi, Hasan
    Al-Zidan, Radhwan N.
    Conner, Matthew T.
    Salman, Mootaz M.
    BIOENGINEERING-BASEL, 2021, 8 (02): : 1 - 20
  • [50] An efficient Gait Dynamics classification method for Neurodegenerative Diseases using Brain signals
    Mole, S. S. Sreeja
    Sujatha, K.
    JOURNAL OF MEDICAL SYSTEMS, 2019, 43 (08)